Abstract:Introduction Ehlers Danlos syndromes (EDS) constitute a group of connective tissue diseases characterized by collagen synthesis abnormalities. The manifestation of EDS varies among the affected individuals, but most commonly present with hypermobility of joint, hyperextensibility of the skin, and tissue fragility. The literature described different comorbidities in patients with EDS. We intend to describe the clinical characteristics of these patients and further focus on cardiovascular complications. Methods We conducted a retrospective cohort study using the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP-NIS) 2017 database, which represents a 20% sample of all payer hospitalizations in the United States. We utilized the International Classification of Diseases version 10 (ICD-10) to identify patients with EDS and other comorbidities. Due to that large available pool of controls, we will perform Exact Matching (EM) methods to match for age, gender, race, and type of insurance (as a surrogate for socioeconomic status) to identify a balanced cohort of controls, then compare the outcomes. Alpha value less than 0.05 was considered statistically significant. Results A total of 2,430 admissions with EDS were identified. Mean age was 36 years (SD 17 years). Around 85% of admitted patients were females (n=2,070). Inpatient mortality rate was 0.7% (n=18). Cardiovascular complications comprised 7% of admissions (n=178). These diagnoses varied between cardiac and vascular presentations, as follows: cardiac arrhythmias 19.1% (n=34), hypertension 19.1% (n=34), heart failure 6.17% (n=11), arterial aneurysms 24.7% (n=44), syncope 8.4% (n=15), and complications involving cardiac device implants 10.1% (n=18). Other less common complications were myocardial infarction, congenital heart abnormalities, and hypotension, which collectively comprised 12% of admission (n=22). Further comparison with general population will be described in the full manuscript. Conclusion Ehlers Danlos Syndrome is a very rare clinical entity. Most common cardiac complications were cardiac arrhythmias, and most common vascular complication was arterial aneurysm.

Enrichment of Patients With Ehlers Danlos Syndrome in Idiopathic Gastroparesis-A Gene Set Enrichment Analysis

Clinical-Genomic Analysis of 1261 Patients with Ehlers–Danlos Syndrome Outlines an Articulo-Autonomic Gene Network (Entome)

Prophylactic application of antibiotics in thoracic surgery. Part III.

Chronic Enteropathy Associated with SLCO2A1 Gene: A Case Report and Literature Review

Chronic enteropathy associated with SLCO2A1 gene: A case report and literature review.

[Gastrointestinal involvement in Ehlers-Danlos syndrome: A case series and systematic review]

Enrichment of Motilin Receptor Loss-of-Function Variants in Gastroparesis

Importance of comprehensive genetic testing for patients with suspected vascular Ehlers–Danlos syndrome: a family case report and literature review

Genetic diagnosis of the Ehlers-Danlos syndromes

High prevalence of gastrointestinal disorders in a large cohort of patients with joint hypermobility

Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis

Low Molecular Weight Heparin Therapy: Is Monitoring Needed?

Cardiovascular Complications In Hospitalized Patients With Ehlers Danlos Syndrome (EDS) A Retrospective Cohort Study

Clinical and Molecular Characterization of a Novel Homozygous Frameshift Variant in AEBP1-Related Classical-like Ehlers Danlos Syndrome Type 2 with Comparison to Previously Reported Rare Cases

Expression profiling identifies key genes and biological functions associated with eosinophilic esophagitis in human patients

Pediatric Hospital Indications , Hospital Course , and Complexity of Patients Undergoing Tracheostomy at a Tertiary Care

Integrative Multi-Omics Approach in Vascular Ehlers–Danlos Syndrome: Further Insights into the Disease Mechanisms by Proteomic Analysis of Patient Dermal Fibroblasts

[Study of leukocyte phagocytic activity using flow cytometry and hydrophilic fluorochrome-labeled microspheric particles].

Clinical diagnosis of the monogenic Ehlers-Danlos syndromes

Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis.

Case Report: Identification and Functional Analysis of a Homozygous Synonymous Variant in the PLOD1 Gene in a Chinese Neonatal With the Ehlers–Danlos Syndrome